Tristel Share News (TSTL)

Tristel Information

Buy TSTL Shares
Add TSTL to Watchlist
Add TSTL to Alert

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 435.00

Bid: 430.00

Ask: 440.00

Change: -5.00 (-1.14%)

Spread: 10.00 (2.326%)

Open: 440.00

High: 440.00

Low: 435.00

Prev. Close: 440.00

Last checked at -

Tristel's Hospital Surface Disinfection Focus Helps It Weather Virus

Mon, 19th Oct 2020 11:16

(Alliance News) -Â Infection prevention products provider Tristel PLC on Monday said annual profit grew as hospital surface disinfectant sales helped to offset a decline in medical device decontamination sales.

Revenue for the financial year ended June 30 was GBP31.7 million, up 21% from GBP26.2 million the year before. Pretax profit rose 40% to GBP6.6 million from GBP4.7 million.

"We delivered another very sound performance in a year turned on its head by Covid-19, the impact of which was a reduction of GBP0.5 million in medical device decontamination sales and an increase of GBP2 million in hospital surface disinfectant sales," said Chief Executive Paul Swinney.

During the March to June period, when the impact of Covid-19 was at its greatest, global sales were GBP11.8 million compared to GBP9.1 million in the same period last year, an increase of 30%. Medical device decontamination product sales accounted for 74% of sales in this period, while sales of hospital surface disinfection products accounted for 15%.

Tristel said it was able to steer its way through the early Covid-19 crisis by mitigating the fall in demand for its primary product portfolio via a rapid increase in supply of its hospital surface disinfection products.

Turning to the recently-started financial year, Swinney said the company has seen a "gradual recovery" in demand for medical device products in all its markets in the first quarter.

"Since February, we have acquired a significant number of hospital customers for our surface disinfectant products. We expect this build-up of our hospital surface disinfection business to continue throughout this and future years. It is a key strategic focus of the company," he added.

While further Covid-19 lockdowns may "temporarily interrupt our group's forward momentum", Tristel is optimistic for the year's trading outlook.

Tristel raised its full-year dividend by 12% to 6.18 pence.

Shares in Tristel were up 2.2% at 509.00p in London on Monday.

By Lucy Heming;Â lucyheming@alliancenews.com

More News

9 Sep 2010 14:44

London afternoon: ARM gives Footsie a hand

Mining stocks continue to drive the market's advance, despite metal prices falling back as concerns grow about the Chinese authorities' determination to cool off the economy, with the latest report from the People's Republic suggesting that the government is set to introduce measures to curb propert

28 Jun 2010 16:33

Non-exec's firm cashes in at Lancashire

Lancashire Holdings non-executive director Barry Volpert is chief executive of private equity firm Crestview, which has raised more than £4.7m from the sale of shares in the property, aviation and marine insurer. The share prices of the five separate disposals varied from 497p to just over 500p. C

8 Mar 2010 09:00

Tristel profits climb after acquisition

Disinfectant supplier Tristel posted a rise in turnover and profits in the six months to December 31 as it proceeded with the integration of a portfolio of products it acquired from Medichem. Pre-tax profits climbed to £656,000 from £469,000 over the same period the previous year as revenues climbe

4 Dec 2009 16:26

Ultra boss sells

Ultra Electronics chief executive Douglas Caster has generated £5.85m from the sale of just over two-fifths of his shareholding in the defence electronics supplier. He states in the announcement that the sale was for "family and tax planning reasons". Caster has also transferred his remaining 63

9 Nov 2009 11:43

Small caps round-up: Nautical Petroleum, ThirdForce, Allied Gold...

Oil group Nautical Petroleum reported 'significant progress' in its asset portfolio in the year to June 30 and said it expects its assets to rise in value once they move into the execution stage. Pre-tax losses for the year totalled £6.63m, compared with £4.52m the previous year. Shares in e-learn

12 Oct 2009 15:49

Comment: Tristel looks to clean up overseas

Tristel chief executive Paul Swinney described the infection and contamination control company's results as 'good, if not spectacular' but his modesty contrasts with his excitement about the prospect of overseas expansion. In the year to June 30, Tristel, whose products are used to combat infection

12 Oct 2009 07:17

Tristel ups divi as profits climb

The continuing struggle to keep infections such as Clostridium difficile out of hospitals helped disinfectant supplier Tristel post a rise in turnover and profits in the year to June 30. Tristel, whose products are based on chlorine dioxide chemistry, said revenues climbed to £6.8m from £6m over th

3 Jul 2009 17:08

Tristel chairman sells

Francisco Soler, non-executive chairman of Tristel, sold £315,680 worth of shares in the disinfectant supplier to satisfy institutional demand following the group's oversubscribed placing. Soler disposed of 769,951 shares in Tristel at 41p each as the group raised £1m to part finance the purchase

3 Jul 2009 07:47

Tristel gets £1m towards portfolio purchase

Disinfectant supplier Tristel has raised £1m to part finance the purchase of a portfolio of infection control products for between £2.15m and £2.4m. It has placed 2.7m shares at 41p each, which will help buy intellectual property and manufacturing rights from Medichem International. The placing was

Latest Share Chat

Tristel Share News (TSTL)

Share Price Information for Tristel (TSTL)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tristel's Hospital Surface Disinfection Focus Helps It Weather Virus

Login to your account

Quickpicks are a member only feature

Login to your account